Log In
Print this Print this

AMG 595

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHuman anti-EGFRvIII (epidermal growth factor receptor) antibody drug conjugate
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today